A multidisciplinary approach is crucial for the better management of breast cancer. All who are active in breast cancer research and clinical care, including advanced trainees, are encouraged to register for online events that apply a multidisciplinary lens to improving outcomes for patients.
Breast Cancer Grand Round
Join this fortnightly online meeting showcasing the latest developments in breast cancer related research, locally, nationally and globally.
Wednesday 23 March 12.30 - 1.30pm
Associate Professor Logan Walker - Genetic modifiers of risk of familial breast cancer
In collaboration with the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), researchers at the University of Otago conducted the largest genome-wide association study of CNVs and breast cancer risk for 26,000 BRCA1 and BRCA2 pathogenic variant carriers. Findings have potential implications for clinical risk assessment and management of BRCA1 carriers.
Gain a greater understanding of how each discipline supports patient care and how they potentially intersect and overlap. Sessions focus on key issues in breast cancer management, including where there is recent change and new directions, and where multidisciplinary decision-making is essential for optimal patient care.
Wednesday 30 March 5.30 - 7.00pm
Axillary Management - co-presented with Breast Surgeons of Australia and New Zealand
Recent advancements in sentinel node biopsy mean that many patients can avoid lymphoedema, a common side effect of axillary lymph node dissection (ALND). Surgical de-escalation has also proven to have equivalent oncological outcomes with reduced complications. Currently axillary radiotherapy is increasingly used as an alternative to ALND, however the increasing use of neoadjuvant chemotherapy adds further complexity.
Join an expert panel of surgeons from across Australia and New Zealand for a close look at axillary dissection and de-escalating axillary surgery after neoadjuvant chemotherapy, with opportunity for discussion.
This educational programming is an initiative of the VCCC Alliance Research and Education Lead (R&E Lead) breast cancer program and is facilitated by Professor Bruce Mann, surgical oncologist and Director of Breast Cancer Services Peter Mac, Royal Women's and Royal Melbourne; and Dr Belinda Yeo, medical oncologist, Austin Health, and clinician scientist, Olivia Newton-John Cancer Research Institute.
